Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

NCT02221284 · clinicaltrials.gov ↗
COMPLETED
Status
964
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda